Showing results for "#Bharat Biotech"
Drug regulator approves Corbevax, Covovax, anti-viral drug...
Union Health Minister Mansukh Mandaviya on Tuesday said that the Central Drug Authority CDSCO has approved the Serum Institute of India's COVID-19...
Covaxin Meets WHO Criteria For Delta, Shows Lancet Study: Bharat...
Two doses of COVID-19 vaccine Covaxin (BBV152) are 50 per cent effective against symptomatic COVID-19 disease, according to the first real-world...
Covaxin 77.8 pc effective against COVID-19: Lancet study
Bharat Biotech's vaccine Covaxin has demonstrated that it is 77.8 per cent effective against symptomatic Covid-19, through evaluation of 130 confirmed...
Covaxin to be part of UK govt’s approved list from November 22
The UK government has said that Covaxin will be added to its list of approved COVID-19 vaccines for international travellers from November 22, meaning...
WHO clears Bharat Biotech's Covaxin for Emergency Use listing
The Technical Advisory Group (TAG), an independent advisory committee of the World Health Organisation (WHO), has recommended Emergency Use Listing...
Covaxin gets shelf life extension up to 12 months
Vaccine maker Bharat Biotech on Wednesday said the Central Drugs Standard Control Organisation (CDSCO) has approved the extension of shelf life of its...
Australia formally recognises India's Covaxin
Australia's medicines and medical devices regulator on Monday formally recognised India's Covaxin, a vaccine against the coronavirus as the country's...
Covaxin recognized by Australia
Australia on Monday recognised Bharat Biotech's Covaxin for allowing entry of travellers who had received the vaccine.